Open Now: The Global ETF Survey Take the Survey →

Advertisement
Advertisement

FXHvsRSPHETF Comparison

ETF 1
FXH

First Trust Health Care AlphaDEX Fund ETF

This fund is part of
US Health Care
+0.24%
VS
ETF 2
RSPH

Invesco S&P 500® Equal Weight Health Care ETF

This fund is part of
US Health Care
+0.24%

First Trust Health Care AlphaDEX Fund ETF (FXH) and Invesco S&P 500® Equal Weight Health Care ETF (RSPH) belong to the same industry segment: US Health Care. FXH's top 1 sector exposures are Healthcare. In contrast, RSPH's top sector exposures are Healthcare and Consumer Non-Cyclicals. FXH is more expensive with a Total Expense Ratio (TER) of 0.61%, versus 0.4% for RSPH. FXH is up 13.05% year-to-date (YTD) with +$32M in YTD flows. RSPH performs worse with 11.05% YTD performance, and -$41M in YTD flows. Run a side-by-side ETF comparison of FXH and RSPH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

FXH vs RSPH performance and flow charts

Performance

-3.0-2.0-1.00.01.02.03.0%Jul 6Jul 13Jul 20Jul 27Aug 3

Cumulative Flows

0 M10 M20 M30 M40 M50 M60 MJul 6Jul 13Jul 20Jul 27Aug 3

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 08/05/2026
1M3MYTD1Y3Y5Y
Perf.
FXH
RSPH
+2.11%+2.60%
+13.64%+15.94%
+13.05%+11.05%
+29.00%+26.03%
+23.93%+21.39%
+6.09%+17.98%
Flows
FXH
RSPH
+$57M+$25M
+$88M-$10M
+$32M-$41M
+$1M-$63M
-$594M-$347M
-$457M-$249M
Volatility and drawdown
3M1Y3Y5Y
Volatility
FXH
RSPH
+15.87%+17.86%
+15.83%+15.86%
+15.52%+15.41%
+16.88%+16.55%
Max drawdown
FXH
RSPH
-3.81%-3.58%
-12.07%-10.87%
-17.66%-16.96%
-29.40%-21.91%
Max drawdown duration
FXH
RSPH
20d20d
168d116d
395d434d
1759d817d
Trading data

Create an account to view trading data

Join for free
FXH
RSPH
Last sale
8/6/2026 at 1:30 PM
$127.59
$35.13
Previous close
08/06/2026
$128.30
$35.24
Consolidated volume
08/06/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of July 31, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
FXH
RSPH
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 8/6/2026 at 1:30 PM
Live
Closed
FXH
RSPH
Last price
$127.59
$35.13
1D performance
-0.55%
-0.31%
AuM$1.08 B$777.95 M
E/R0.61%0.4%
Characteristics
FXH
RSPH
Management strategyPassivePassive
ProviderFirst TrustInvesco
BenchmarkStrataQuant Health Care IndexS&P 500 Equal Weight Health Care Index
N° of holdings7559
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateMay 8, 2007November 1, 2006
ESGNoNo
Advertisement
Exposure

Countries

FXH
USA
96.02%
Other
3.98%
RSPH
USA
96.71%
Other
3.29%

Sectors

FXH
Healthcare
99.85%
Other
0.15%
RSPH
Healthcare
98.29%
Other
1.71%
Advertisement

Diversification

FXH

Total weight of top 15 holdings out of 15

38.89%
RSPH

Total weight of top 15 holdings out of 15

27.58%

Top 15 holdings

Data as of June 30, 2026
FXH
Humana, Inc.
4.74%
Organon & Co.
3.63%
DaVita, Inc.
2.98%
Elevance Health, Inc.
2.86%
Molina Healthcare, Inc.
2.80%
Exelixis, Inc.
2.53%
Incyte Corp.
2.43%
Solventum Corp.
2.41%
Biogen, Inc.
2.30%
Cardinal Health, Inc.
2.26%
Bio-Rad Laboratories, Inc.
2.14%
The Cigna Group
2.09%
Chemed Corp.
2.05%
Zimmer Biomet Holdings, Inc.
1.87%
Illumina, Inc.
1.80%
RSPH
Moderna, Inc.
2.35%
Bio-Techne Corp.
2.17%
Charles River Laboratories International, Inc.
1.86%
Vertex Pharmaceuticals, Inc.
1.81%
AbbVie, Inc.
1.81%
Mettler-Toledo International, Inc.
1.79%
Revvity, Inc.
1.79%
Biogen, Inc.
1.79%
Cardinal Health, Inc.
1.77%
DaVita, Inc.
1.76%
Baxter International, Inc.
1.74%
Merck & Co., Inc.
1.74%
Incyte Corp.
1.73%
Henry Schein, Inc.
1.73%
Stryker Corp.
1.73%
Frequently asked questions about FXH and RSPH

How have the FXH and RSPH ETFs performed in 2026?

As of August 5, 2026, FXH is up 13.05% year-to-date (YTD), while RSPH has returned 11.05%. That puts FXH better performer ahead so far this year.

Which ETF is attracting more investor money: FXH or RSPH?

Year-to-date, the FXH ETF saw +$32M in flows, compared to -$41M for RSPH.

Which ETF is more volatile: FXH or RSPH?

Over the past year, FXH had a volatility of 15.83%, while RSPH experienced 15.86%.

Which ETF is bigger: FXH or RSPH?

As of August 5, 2026, FXH holds $1.08 B in assets under management (AUM), while RSPH manages $777.95 M.

What sectors do the FXH and RSPH ETFs invest in?

FXH leans toward sectors like Healthcare. Meanwhile, RSPH focuses on Healthcare.

What are the top holdings of the FXH ETF and RSPH ETF?

FXH top holdings include Humana, Inc., Organon & Co. and DaVita, Inc.. RSPH holds in its top three: Moderna, Inc., Bio-Techne Corp. and Charles River Laboratories International, Inc..

Which ETF is more diversified: FXH or RSPH?

FXH holds 75 securities with 38.89% of its assets in the top 15. RSPH has 59 securities and a top 15 weight of 27.58%.

Advertisement
Latest news about FXH & RSPH
Advertisement
Advertisement
Advertisement
ETF INVESTOR RESOURCES

Expert-Built ETF Portfolios, All in One Place

Don’t start from scratch. Discover ready-made ETF portfolios built by professionals to match different goals, timelines, and market views. Use them as inspiration or as a starting point for your own allocation.

Portfolio Builder